| NDC Code | 72579-125-00 |
|---|
| Package Description | 1 VIAL, GLASS in 1 CARTON (72579-125-00) / 15 mL in 1 VIAL, GLASS |
|---|
| Product NDC | 72579-125 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Tevimbra |
|---|
| Non-Proprietary Name | Tislelizumab-jsgr |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20260713 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761232 |
|---|
| Manufacturer | BeOne Medicines USA, Inc. |
|---|
| Substance Name | TISLELIZUMAB |
|---|
| Strength | 10 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
|---|